Exploring how palliative and hospice teams balance symptom relief with medication risks. Covers pain, delirium, special populations, and emerging digital tools.
MoreArchive: 2026/03
Understand why generic drugs often sit approved but unavailable, exploring the role of patent litigation and regulatory delays from 2023 to 2025.
MoreDiscover the link between trimethoprim antibiotics and dangerous potassium spikes. Learn who is at risk, how doctors monitor levels, and safer alternatives to protect your heart.
MorePost-market surveillance uncovers dangerous side effects that clinical trials miss. Learn how real-world use, reporting systems, and new technologies help catch hidden risks in drugs and medical devices after approval.
MoreCompulsory licensing lets governments override patents to make life-saving drugs affordable. Used during health crises, it balances innovation with access. Countries like India and Thailand have slashed drug prices using this tool - and it's gaining momentum.
MoreLearn how to coordinate care between your OB/GYN and psychiatrist during pregnancy and breastfeeding to safely manage psychiatric medications. Evidence-based guidelines, safe drug options, and step-by-step coordination strategies.
MoreWeight loss directly reduces sleep apnea severity and CPAP pressure needs. Losing just 10% of body weight can cut breathing pauses by half and often eliminate the need for high-pressure CPAP settings. The link between BMI and sleep apnea is strong, measurable, and reversible.
MoreCounterfeit medications are a deadly global problem. Learn the warning signs of fake pills, how they're sold online, and exactly how to protect yourself from dangerous fakes that look just like the real thing.
MoreBiosimilars are billed under Medicare Part B using unique HCPCS codes and a 106% reimbursement formula tied to the reference product’s price. This structure unintentionally discourages adoption, as providers earn more from higher-priced drugs. Learn how billing works, why U.S. adoption lags behind Europe, and what reforms are being considered.
MoreGeneric drugs cost 80-85% less than brand-name drugs because they don't repeat expensive clinical trials or carry patent monopolies. They're chemically identical, FDA-approved, and backed by fierce competition - making them safe, effective, and affordable.
MoreStimulants for ADHD improve focus but can raise blood pressure and disrupt sleep. Learn the real risks, how to monitor them, and what alternatives exist - backed by the latest research.
MoreGrapefruit juice can dangerously increase simvastatin levels in the blood, raising the risk of muscle damage and kidney failure. Learn why even small amounts matter and what statins are safer to take with citrus.
More